Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Hepatocellular Carcinoma
Related studies linked through entity extraction aliases.
Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2
Role of LncRNA H19 in The Regulation of IGF-1R Expression
- Status
- COMPLETED
- Phase
- N/A
Serum Visfatin and Serum Vaspin in Patients With Hepatocellular Carcinoma on Top of Liver Cirrhosis
- Status
- COMPLETED
- Phase
- N/A
68Ga-PSMA-Dual-Contrast PET/MRI or PET/CT for Early Detection of Liver Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Redirected HBV-Specific T Cells in Patients With HBV-related HCC (SAFE-T-HBV)
- Status
- RECRUITING
- Phase
- PHASE1
Standard Versus Radiobiologically-Guided Dose Selected SBRT in Liver Cancer
- Status
- RECRUITING
- Phase
- NA
Study of HX008 in Combination With Bevacizumab or Lenvatinib for the Treatment of Advanced Hepatocellular Carcinoma (HCC)
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;
- Status
- RECRUITING
- Phase
- NA
A Study of Anti-PD-1/CTLA-4 Bispecific AK104 Alone or in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Neoadjuvant Atezo, Adjuvant Atezo + Beva Combined With RF Ablation of Small HCC: a Multicenter Randomized Phase II Trial
- Status
- RECRUITING
- Phase
- PHASE2
Cryoablation Combined With Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Low Contrast Agent and Radiation Dose Protocol for Liver CT in Patients With HCC
- Status
- COMPLETED
- Phase
- NA
Combined Therapy for Hepatocellular Carcinoma >3-<5 cm
- Status
- COMPLETED
- Phase
- NA
A Study to Compare the Effectiveness and Safety of IBI310 Combined With Sintilimab Versus Sorafenib in the First-line Treatment of Advanced HCC
- Status
- COMPLETED
- Phase
- PHASE3
Blood Sample Collection for Experimental Blood Test to Track Liver Cancer
- Status
- COMPLETED
- Phase
- N/A
CT Perfusion Parameters Predict Vascular Pattern in Hepatocellular Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
A Study of TACE Combined With Atezolizumab Plus Bevacizumab or TACE Alone in Patients With Untreated Heaptocellular Carcionma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Radomised Phase II Study of MTL-CEBPA Plus Sorafenib or Sorafenib Alone
- Status
- COMPLETED
- Phase
- PHASE2
Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors
- Status
- COMPLETED
- Phase
- PHASE2